{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:17:38Z","timestamp":1793506658895,"version":"4.5.0"},"reference-count":115,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T00:00:00Z","timestamp":1409616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>There is currently no vaccine available for human use for any parasitic infections, including the helminth disease, schistosomiasis. Despite many researchers working towards this goal, one of the focuses has been on identifying new antigenic targets. The bar to achieve protective efficacy in humans was set at a consistent induction of 40% protection or better by the World Health Organisation (WHO), and although this is a modest goal, it is yet to be reached with the six most promising schistosomiasis vaccine candidates (Sm28GST, IrV5, Sm14, paramyosin, TPI, and Sm23). Adjuvant selection has a large impact on the effectiveness of the vaccine, and the use of adjuvants to aid in the stimulation of the immune system is a critical step and a major variable affecting vaccine development. In addition to a comprehensive understanding of the immune system, level of protection and the desired immune response required, there is also a need for a standardised and effective adjuvant formulation. This review summarises the status of adjuvants that have been or are being employed in schistosomiasis vaccine development focusing on immunisation outcomes at preclinical and clinical stages.<\/jats:p>","DOI":"10.3390\/vaccines2030654","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T10:12:38Z","timestamp":1409652758000},"page":"654-685","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Schistosome Vaccine Adjuvants in Preclinical and  Clinical Research"],"prefix":"10.3390","volume":"2","author":[{"given":"Rachel","family":"Stephenson","sequence":"first","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia,  QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[{"name":"Molecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland Q4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"McManus","sequence":"additional","affiliation":[{"name":"Molecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland Q4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia,  QLD 4072, Australia"},{"name":"School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2014,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.it.2010.11.005","article-title":"To B or not to B: B cells and the Th2-type immune response to helminths","volume":"32","author":"Harris","year":"2011","journal-title":"Trends Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrmicro2438","article-title":"Developing vaccines to combat hookworm infection and intestinal schistosomiasis","volume":"8","author":"Hotez","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"McManus","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri843","article-title":"The immunobiology of schistosomiasis","volume":"2","author":"Pearce","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4269\/ajtmh.13-0467","article-title":"Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals","volume":"90","author":"Mo","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mata, E., Salvador, A., Igartua, M., Hernandez, R.M., and Pedraz, J.L. (2013). Malaria vaccine adjuvants: Latest update and challenges in preclinical and clinical research. Biomed. Res. Int.","DOI":"10.1155\/2013\/282913"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-3024.2005.00789.x","article-title":"Modulation of the host\u2019s immune response by schistosome larvae","volume":"27","author":"Jenkins","year":"2005","journal-title":"Parasite Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/14760584.3.3.315","article-title":"Current status and future prospects for a vaccine against schistosomiasis","volume":"3","author":"Lebens","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2567.2008.02826.x","article-title":"The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo","volume":"125","author":"Atochina","year":"2008","journal-title":"Immunology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e42490","DOI":"10.1371\/journal.pone.0042490","article-title":"Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9\/10 on liver non-parenchymal cells","volume":"7","author":"Liang","year":"2012","journal-title":"PLoS One"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pt.2005.01.003","article-title":"Schistosomes: The road from host-parasite interactions to vaccines in clinical trials","volume":"21","author":"Capron","year":"2005","journal-title":"Trends Parasitol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/092986708783503249","article-title":"Self-Adjuvanting lipopeptide vaccines","volume":"15","author":"Moyle","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-61779-151-2_18","article-title":"Lipid-Core-Peptide system for self-adjuvanting synthetic vaccine delivery","volume":"751","author":"Skwarczynski","year":"2011","journal-title":"Bioconjug. Protoc. Strateg. Methods Second Ed."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1086\/313883","article-title":"Improving vaccine performance with adjuvants","volume":"30","author":"Vogel","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants\u2014A classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parint.2005.02.004","article-title":"Update on paramyosin in parasitic worms","volume":"54","author":"Gobert","year":"2005","journal-title":"Parasitol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Powell, M.F., and Newman, M.J. (1995). Vaccine design: The subunit and adjuvant approach, Plenum Press.","DOI":"10.1007\/978-1-4615-1823-5"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-3024.2011.01330.x","article-title":"Novel immunomic technologies for schistosome vaccine development","volume":"34","author":"McWilliam","year":"2012","journal-title":"Parasite Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imbio.2005.06.004","article-title":"Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine","volume":"211","author":"Pacifico","year":"2006","journal-title":"Immunobiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.27057","article-title":"Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schostosomiasis vaccine","volume":"10","author":"Dougall","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.actatropica.2005.08.005","article-title":"Development of a vaccine against Schistosoma japonicum in China: A review","volume":"96","author":"Wu","year":"2005","journal-title":"Acta Trop."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0020-7519(98)00222-7","article-title":"Schistosoma bovis: Vaccine effects of a recombinant homologous glutathione S-transferase in sheep","volume":"29","author":"Boulanger","year":"1999","journal-title":"Int. J. Parasitol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xiong, Y.N., Zhang, M., Hong, Y., Wei, M.M., Ai, D.Z., Meng, P.P., Han, Y.H., Fu, Z.Q., Shi, Y.J., and Yang, J.M. (2013). Characterization analysis of Schistosoma japonicum plasma membrane repair relative gene myoferlin. PLoS One.","DOI":"10.1371\/journal.pone.0066396"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.parint.2004.01.006","article-title":"A vaccine against Asian schistosomiasis","volume":"53","author":"McManus","year":"2004","journal-title":"Parasitol. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-3024.2005.00784.x","article-title":"Prospects for development of a transmission blocking vaccine against Schistosoma japonicum","volume":"27","author":"McManus","year":"2005","journal-title":"Parasite Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-3083.2012.02768.x","article-title":"Adjuvant selection for vaccination against murine schistosomiasis","volume":"76","author":"Tallima","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"ref_27","first-page":"83","article-title":"Nanoparticles as a vaccine adjuvant of anti-idiotypic antibody against schistosomiasis","volume":"117","author":"Feng","year":"2004","journal-title":"Chin. Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ohs, I., Windmann, S., Wildner, O., Dittmer, U., and Bayer, W. (2013). Interleukin-Encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection. PLoS One.","DOI":"10.1371\/journal.pone.0082528"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4049\/jimmunol.167.1.442","article-title":"Lacto-N-fucopentaose III found on Schitosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response","volume":"167","author":"Okano","year":"2001","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.4049\/jimmunol.138.10.3448","article-title":"A purified 28,000 dalton protein from Schistosoma-mansoni adult worms protects rats and mice against experimental schistosomiasis","volume":"138","author":"Balloul","year":"1987","journal-title":"J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-3024.1991.tb00545.x","article-title":"Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental-infection with schistosoma-mansoni","volume":"13","author":"Boulanger","year":"1991","journal-title":"Parasite Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.pt.2007.08.012","article-title":"Recombinant expression systems: The obstacle to helminth vaccines?","volume":"23","author":"Geldhof","year":"2007","journal-title":"Trends Parasitol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bmb\/62.1.139","article-title":"Vaccine development against schistosomiasis from concepts to clinical trials","volume":"62","author":"Capron","year":"2002","journal-title":"Br. Med. Bull."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0264-410X(99)00541-1","article-title":"Vaccination of domestic pig with recombinant paramyosin against Schistosoma japonicum in China","volume":"18","author":"Chen","year":"2000","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S0074-02762001000900019","article-title":"r-Sm14-pRSETA efficacy in experimental animals","volume":"96","author":"Ramos","year":"2001","journal-title":"Memorias Do Instituto Oswaldo Cruz"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0264-410X(03)00300-1","article-title":"An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis","volume":"22","author":"Vilar","year":"2003","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Farias, L.P., Rodrigues, D., Cunna, V., Rofatto, H.K., Faquim-Mauro, E.L., and Leite, L.C.C. (2012). Schistosoma mansoni venom allergen like proteins present differential allergic responses in a murine model of airway inflammation. PLoS Negl. Trop. Dis.","DOI":"10.1371\/journal.pntd.0001510"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm1430","article-title":"Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis","volume":"12","author":"Tran","year":"2006","journal-title":"Nat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.actatropica.2012.07.007","article-title":"Schistosoma mansoni schistosomula tegument (Smteg) immunization in absence of adjuvant induce IL-10 production by CD4+ cells and failed to protect mice against challenge infection","volume":"124","author":"Araujo","year":"2012","journal-title":"Acta Trop."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vetpar.2005.04.038","article-title":"Characterization of a novel vaccine candidate and serine proteinase inhibitor from Schistosoma japonicum (Sj serpin)","volume":"131","author":"Yan","year":"2005","journal-title":"Vet. Parasitol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0264-410X(94)00045-O","article-title":"Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental-infection with Chinese Schistosoma-japonicum","volume":"13","author":"Liu","year":"1995","journal-title":"Vaccine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-4017(00)00263-6","article-title":"Vaccination of mice against Schistosoma bovis with a recombinant fatty acid binding protein from Fasciola hepatica","volume":"91","author":"Abane","year":"2000","journal-title":"Vet. Parasitol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7883\/yoken.63.166","article-title":"Intranasal administration of Schistosoma japonicum paramyosin induced robust long-lasting systemic and local antibody as well as delayed-type hypersensitivity responses, but failed to confer protection in a mouse infection model","volume":"63","author":"Kohama","year":"2010","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0001-706X(03)00195-5","article-title":"In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens","volume":"88","author":"Osman","year":"2003","journal-title":"Acta Trop."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Xu, X.D., Zhang, D.M., Sun, W., Zhang, Q.F., Zhang, J.J., Xue, X.Y., Shen, L.H., and Pan, W.Q. (2009). A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens. BMC Infect. Dis.","DOI":"10.1186\/1471-2334-9-54"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.vaccine.2013.12.057","article-title":"Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons","volume":"32","author":"Karmakar","year":"2014","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0264-410X(01)00420-0","article-title":"Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection","volume":"20","author":"Zhang","year":"2002","journal-title":"Vaccine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S1357-2725(03)00105-5","article-title":"A Schistosoma japonicum very low-density lipoprotein-binding protein","volume":"35","author":"Fan","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-3024.2005.00814.x","article-title":"Investigation of recombinant Schistosoma japonicum paramyosin fragments for immunogenicity and vaccine efficacy in mice","volume":"28","author":"Zhang","year":"2006","journal-title":"Parasite Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-3024.2001.00369.x","article-title":"Vaccine efficacy of recombinant cathepsin D aspartic protease from Schistosoma japonicum","volume":"23","author":"Verity","year":"2001","journal-title":"Parasite Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijpara.2012.06.002","article-title":"The insulin receptor is a transmission blocking veterinary vaccine target for zoonotic Schistosoma japonicum","volume":"42","author":"You","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"ref_52","unstructured":"Gameiro, S.R. (2008). Pulmonary delivery of liposome-based vaccines: Application to a murine model of schistosoma mansoni infection. [Ph.D. Thesis, State University of New York]."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0264-410X(96)00048-5","article-title":"Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glutathione S-transferase","volume":"14","author":"Ivanoff","year":"1996","journal-title":"Vaccine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/infdis\/jir545","article-title":"Preclinical prophylactic efficacy testing of sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic","volume":"204","author":"Ahmad","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.vaccine.2011.01.040","article-title":"Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models","volume":"29","author":"Torben","year":"2011","journal-title":"Vaccine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"E781","DOI":"10.1016\/j.ijid.2010.02.2266","article-title":"Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice","volume":"14","author":"Ahmad","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.vaccine.2004.04.031","article-title":"The protective effect of a Schistosoma japonicum chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12","volume":"23","author":"Zhu","year":"2004","journal-title":"Vaccine"},{"key":"ref_58","first-page":"899","article-title":"Studies on effect enhancement of vegetal polysaccharide on Schistosoma japonicum DNA vaccine pv1223","volume":"41","author":"Cao","year":"2006","journal-title":"Chin. Pharm. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/j.vaccine.2008.05.034","article-title":"Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26 kDa GST plasmid DNA vaccine in mice","volume":"26","author":"Wei","year":"2008","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1645\/GE-3186.1","article-title":"Vaccine-induced protection against murine Schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines","volume":"99","author":"Tallima","year":"2013","journal-title":"J. Parasitol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1073\/pnas.85.15.5678","article-title":"Induction of protective immunity against Schistosoma-mansoni by vaccination with Schistosome paramyosin (Sm97), a nonsurface parasite antigen","volume":"85","author":"Pearce","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"El Ridi, R., Tallima, H., Selim, S., Donnelly, S., Cotton, S., Santana, B.G., and Dalton, J.P. (2014). Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity. PLoS One.","DOI":"10.1371\/journal.pone.0085401"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2008.10.035","article-title":"The effect of quil a adjuvant on the course of experimental Fasciola hepatica infection in sheep","volume":"27","author":"Hacariz","year":"2009","journal-title":"Vaccine"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-1759(92)90093-9","article-title":"Comparison of Freund and Ribi adjuvants for inducing antibodies to the synthetic antigen (TG)-AL in rabbits","volume":"152","author":"Deeb","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"ref_65","unstructured":"Sabin Vaccine Institute Schistosimiasis Vaccine: Project Status. Available online:http:\/\/www.Sabin.Org\/programs\/schistosomiasis-vaccine\/project-status."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"17585","DOI":"10.1073\/pnas.1207308109","article-title":"Adjuvant solution for pandemic influenza vaccine production","volume":"109","author":"Clegg","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Coler, R.N., Baldwin, S.L., Shaverdian, N., Bertholet, S., Reed, S.J., Raman, V.S., Lu, X.H., DeVos, J., Hancock, K., and Katz, J.M. (2010). A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PLoS One.","DOI":"10.1371\/journal.pone.0013677"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: Current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1515\/znc-2009-3-422","article-title":"Cross-Reactivity of Schistosoma mansoni-Fasciola gigantica influenced by saponins","volume":"64","author":"Maghraby","year":"2009","journal-title":"Z. Fur. Naturforsch. C J. Biosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biologicals.2010.06.002","article-title":"Mode of action of adjuvants: Implications for vaccine safety and design","volume":"38","author":"Mastelic","year":"2010","journal-title":"Biologicals"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2006.08.030","article-title":"Identitication of pentadecapeptide mimicking muramyl peptide","volume":"25","author":"Laman","year":"2007","journal-title":"Vaccine"},{"key":"ref_72","first-page":"201","article-title":"Potentiation of Schistosome granuloma formation\u2014By lentinan\u2014T-cell adjuvant","volume":"94","author":"Byram","year":"1979","journal-title":"Am. J. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0198-8859(99)00136-6","article-title":"Lewis(x)-containing oligosaccharide attenuates schistosome egg antigen-induced immune depression in human schistosomiasis","volume":"61","author":"Velupillai","year":"2000","journal-title":"Hum. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"R759","DOI":"10.1152\/ajpregu.00293.2004","article-title":"The viral mimic, polyinosinic: Polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism","volume":"287","author":"Fortier","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.actatropica.2011.10.008","article-title":"Polyinosinic-Polycytidylic acid attenuates hepatic fibrosis in C57BL\/6 mice with Schistosoma japonicum infection","volume":"121","author":"Hou","year":"2012","journal-title":"Acta Trop."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1073\/pnas.94.20.10833","article-title":"Immunostimulatory oligodeoxynucleotides containing the cpg motif are effective as immune adjuvants in tumor antigen immunization","volume":"94","author":"Weiner","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00003086-199101000-00002","article-title":"The classic: The treatment of malignant-tumors by repeated inoculations of erysipelas-with a report of 10 original cases","volume":"262","author":"Coley","year":"1991","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial-DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0001-706X(03)00062-7","article-title":"Progress towards a vaccine for schistosomiasis","volume":"86","author":"Pearce","year":"2003","journal-title":"Acta Trop."},{"key":"ref_80","first-page":"609","article-title":"CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26gst","volume":"4","author":"Lu","year":"2013","journal-title":"Biomed. Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Wang, X.F., Dong, L.Y., Ni, H.C., Zhou, S., Xu, Z.P., Hoellwarth, J.S., Chen, X.J., Zhang, R.B., Chen, Q.Y., and Liu, F. (2013). Combined TLR7\/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine. PLoS Negl. Trop. Dis.","DOI":"10.1371\/journal.pntd.0002164"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.4049\/jimmunol.174.10.6292","article-title":"Electroporation as a \u201cprime\/boost\u201d strategy for naked DNA vaccination against a tumor antigen","volume":"174","author":"Buchan","year":"2005","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00436-009-1646-z","article-title":"Prime-Boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine","volume":"105","author":"Ahmad","year":"2009","journal-title":"Parasitol. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-3024.2003.00651.x","article-title":"A DNA-prime\/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection","volume":"25","author":"Skelly","year":"2003","journal-title":"Parasite Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1128\/CVI.00231-09","article-title":"DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica","volume":"16","author":"Dai","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0264-410X(03)00535-8","article-title":"Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu\/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes","volume":"22","author":"Shalaby","year":"2003","journal-title":"Vaccine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/hv.7.11.17017","article-title":"Schistosomiasis vaccines","volume":"7","author":"Siddiqui","year":"2011","journal-title":"Hum. Vaccines"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF01878491","article-title":"Cytokines as potential vaccine adjuvants","volume":"7","author":"Nohria","year":"1994","journal-title":"Biotherapy"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.2003.12.144","article-title":"Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma","volume":"21","author":"Peterson","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.4049\/jimmunol.156.12.4739","article-title":"Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant","volume":"156","author":"Mountford","year":"1996","journal-title":"J. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.4049\/jimmunol.154.9.4701","article-title":"IL-12 enhances vaccine-induced immunity to Schistosoma-mansoni in mice and decreases T-helper-2 cytokine expression, IgE production, and tissue eosinophilia","volume":"154","author":"Wynn","year":"1995","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00436-008-0887-6","article-title":"Experimental vaccines in animal models for schistosomiasis","volume":"102","author":"Siddiqui","year":"2008","journal-title":"Parasitol. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.vaccine.2008.04.080","article-title":"DNA-Based vaccines protect against zoonotic schistosomiasis in water buffalo","volume":"26","author":"Li","year":"2008","journal-title":"Vaccine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1017\/S0031182005008644","article-title":"Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection","volume":"132","author":"Zhu","year":"2006","journal-title":"Parasitology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.vaccine.2003.07.010","article-title":"IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway","volume":"22","author":"Fonseca","year":"2004","journal-title":"Vaccine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2567.2008.02845.x","article-title":"Control of IL-4 expression in T helper 1 and 2 cells","volume":"124","author":"Gilmour","year":"2008","journal-title":"Immunology"},{"key":"ref_98","first-page":"65","article-title":"Potential role of interleukin 4 and 12 as adjuvants to tegumental antigen in a vaccination model for murine Schistosomiasis mansoni","volume":"6","author":"Samia","year":"2013","journal-title":"Parasitol. United J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0264-410X(99)00532-0","article-title":"IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen","volume":"18","author":"Eberl","year":"2000","journal-title":"Vaccine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/iai.63.9.3241-3244.1995","article-title":"Cytokines as adjuvants for vaccines-antigen-specific responses differ from polyclonal responses","volume":"63","author":"Taylor","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ni.1852","article-title":"Sensing the outside world: TSLP regulates barrier immunity","volume":"11","author":"Ziegler","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/eji.201142337","article-title":"Tslp: From allergy to vaccine adjuvant","volume":"42","author":"Soumelis","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4049\/jimmunol.134.3.1956","article-title":"Induction of protective immunity against Schistosoma-mansoni by a nonliving vaccine is dependent on the method of antigen presentation","volume":"134","author":"James","year":"1985","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.4049\/jimmunol.134.5.3432","article-title":"Induction of protective immunity against Schistosoma-mansoni by a non living vaccine. 1. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts","volume":"134","author":"James","year":"1985","journal-title":"J. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.4049\/jimmunol.136.10.3878","article-title":"Induction of protective immunity against Schistosoma-mansoni by a nonliving vaccine. 4. Fractionation and antigenic properties of a soluble adult worm immunoprophylactic activity","volume":"136","author":"Sher","year":"1986","journal-title":"J. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.4049\/jimmunol.140.8.2753","article-title":"The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis","volume":"140","author":"James","year":"1988","journal-title":"J. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1128\/IAI.69.12.7285-7292.2001","article-title":"Intranasal immunization with recombinant ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A-suum infection in mice","volume":"69","author":"Tsuji","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"ElRidi, R., Tallima, H., P.Dalton, J., and Donnelly, S. (2014). Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases. Front. Genet.","DOI":"10.3389\/fgene.2014.00119"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11882-007-0055-6","article-title":"Proteases as Th2 adjuvants","volume":"7","author":"Chapman","year":"2007","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1258\/0023677011911570","article-title":"An overview of animal models in experimental schistosomiasis and refinements in the use of non-human primates","volume":"35","author":"Farah","year":"2001","journal-title":"Lab. Anim-Uk"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1590\/S0074-02762002000700002","article-title":"Experimental models of schistosoma mansoni infection","volume":"97","author":"Cheever","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0169-4758(99)01569-0","article-title":"The baboon as a non-human primate model of human schistosome infection","volume":"15","author":"Nyindo","year":"1999","journal-title":"Parasitol. Today"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0022149X12000028","article-title":"Zoonotic schistosomiasis in non-human primates: Past, present and future activities at the human-wildlife interface in Africa","volume":"86","author":"Standley","year":"2012","journal-title":"J. Helminthol."},{"key":"ref_114","first-page":"137","article-title":"Schistosomiasis vaccines: Literature review and current status","volume":"4","author":"Ismail","year":"2011","journal-title":"J. Egyp. Parasitol. United"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/erv.10.154","article-title":"Combination adjuvants: The next generation of adjuvants?","volume":"10","author":"Mutwiri","year":"2011","journal-title":"Expert Rev. Vaccines"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/2\/3\/654\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:15:29Z","timestamp":1760217329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/2\/3\/654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,2]]},"references-count":115,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,9]]}},"alternative-id":["vaccines2030654"],"URL":"https:\/\/doi.org\/10.3390\/vaccines2030654","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,2]]}}}